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Abstract
Although retinoic acid (RA) has been implicated as an extrinsic signal regulating forebrain neurogenesis, the processes
regulated by RA signaling remain unclear. Here, analysis of retinaldehyde dehydrogenase mutant mouse embryos lacking
RA synthesis demonstrates that RA generated by Raldh3 in the subventricular zone of the basal ganglia is required for
GABAergic differentiation, whereas RA generated by Raldh2 in the meninges is unnecessary for development of the
adjacent cortex. Neurospheres generated from the lateral ganglionic eminence (LGE), where Raldh3 is highly expressed,
produce endogenous RA, which is required for differentiation to GABAergic neurons. In Raldh32/2 embryos, LGE
progenitors fail to differentiate into either GABAergic striatal projection neurons or GABAergic interneurons migrating to
the olfactory bulb and cortex. We describe conditions for RA treatment of human embryonic stem cells that result in
efficient differentiation to a heterogeneous population of GABAergic interneurons without the appearance of GABAergic
striatal projection neurons, thus providing an in vitro method for generation of GABAergic interneurons for further study.
Our observation that endogenous RA is required for generation of LGE-derived GABAergic neurons in the basal ganglia
establishes a key role for RA signaling in development of the forebrain.
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Introduction
The embryonic forebrain, deriving from the most anterior part
of the neural tube, comprises a complex set of structures in the
developing brain. This complexity arises mainly due to the
heterogeneity of the neurons comprising it in terms of morphol-
ogy, structure, function, and genetic specification. During
forebrain development, the dorsal domain (pallium) gives rise to
the cortex while the ventral region (subpallium) generates the basal
ganglia, i.e. the pallidum and the striatum, which, respectively,
originate from the medial and lateral ganglionic eminences (MGE,
LGE) [1]. The progenitor zones of the subpallial ganglionic
eminences are the origin of chemically diverse populations of
gamma-aminobutyric acid (GABA)ergic interneurons and projec-
tion neurons. GABAergic interneurons are inhibitory local circuit
neurons modulating neuronal activity and synaptic plasticity.
GABAergic neurons comprise ,20% of all neurons within the
cortex and hippocampus and ,95% of the neurons within the
striatum [2–4]. Whereas GABAergic projection neurons generated
in the germinal zones of the LGE migrate radially to the adjacent
striatum, GABAergic interneurons arise from both the MGE and
LGE and migrate using multiple tangential routes to the olfactory
bulb, cortex, and hippocampus [5–8]. Disturbed GABAergic
neuron function has been associated with several neurological
disorders including Huntington’s disease, autism, schizophrenia,
bipolar depression, and epilepsy [9–12]. Thus, a source of
GABAergic neurons for cell replacement therapy may be useful
for treatment of these neurological diseases.
GABAergic neuronal diversity emerges during embryogenesis
and depends on both the timing and the creation of specific
anteroposterior and dorsoventral progenitor domains by the
coordinated action of several transcription factors expressed by
distinct progenitor populations [13,14]. In contrast, little is known
about the extrinsic signaling pathways coordinating GABAergic
specification in the basal ganglia. Retinoic acid (RA) functions as
an extrinsic signal that regulates patterning of rhombomeres in the
hindbrain and neuronal differentiation in the spinal cord [15–17],
but the role of RA in forebrain development remains unclear. RA
is derived from vitamin A through a two-step enzymatic process,
employing retinol dehydrogenase (Rdh10) for oxidation of retinol
to retinaldehyde, and retinaldehyde dehydrogenases Raldh1
(Aldh1a1), Raldh2 (Aldh1a2), and Raldh3 (Aldh1a3) for oxidation
of retinaldehyde to RA, which then functions as a ligand for
nuclear RA receptors [18]. A role for RA signaling during mouse
striatal development is evident after E12.5 when Raldh3, expressed
in the subventricular zone of the LGE [19], plays a required role in
the up-regulation of dopamine receptor D2 expression [20].
Consistent with this finding, loss of RA receptor-beta (RARb)i n
null mutant mice is associated with defects in striatal dopaminergic
neurogenesis after E13.5 resulting in motor behavioral defects
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RA synthesis in the meninges suggested that RA is required for
normal radial expansion of the dorsal cortex [22]. However, other
studies have suggested that RA may not act in the embryonic
cortex, as RA activity was detected in the LGE but not the cortex
[23].
Here, we employ null mutants for Raldh3 (Aldh1a3)a n dRaldh2
(Aldh1a2) to ascertain the anatomical sites, cellular targets, and
consequences of RA signaling in the embryonic forebrain. Our
results provide evidence that Raldh3 expression in the LGE is a
major source of RA production in the embryonic forebrain and is
required for GABAergic differentiation from LGE-derived
progenitors in the basal ganglia. Furthermore, our findings
suggest that RA generated in the meninges by Raldh2 is not
required to stimulate radial expansion of the cortex as previously
suggested. We also report that RA induces GABAergic
differentiation in neurons generated from LGE-derived neuro-
spheres and human embryonic stem cells, thus implicating a role
for RA as a GABAergic differentiation factor both in vivo and
in vitro.
Results
RA Signaling in the Embryonic Forebrain
Although Raldh3 expression in the LGE from E12.5 to early
postnatal stages suggests the LGE is a major site of RA action in
the embryonic forebrain [19,24], Raldh2 and Rdh10 are expressed
in the meninges beginning at E12.5–E13.5, suggesting that RA
synthesized there may regulate corticogenesis [22,25]. In order to
better define the timing and location of RA signaling in the
developing forebrain from E12.5–E14.5, we employed a tissue
explant RA reporter cell assay [26]. Cortex and LGE tissues were
dissected from E12.5 to E14.5 embryos and grown as explants in
co-culture with the RA-reporter cells. As positive controls, eye
(E12.5 to E13.5), which expresses Raldh1 and Raldh3, and
meninges (E14.5), which expresses Raldh2, were dissected from
the same embryos. Reporter cells co-cultured with cortex or LGE
from E12.5 wild-type embryos displayed no RA activity, whereas
eye explants did (Figure 1A–C); lack of RA activity in E12.5 LGE
explants may be due to low initial Raldh3 expression. In
accordance with the increase in Raldh3 expression in the LGE
after E12.5 [19], LGE explants from both E13.5 and E14.5
induced strong RA activity in the surrounding reporter cells
(Figure 1F,I). In contrast, E13.5 and E14.5 cortical explants
remained unable to induce RA activity, whereas meninges and eye
explants at these stages exhibited RA activity (Figure 1D,E,G,H).
To verify that RA activity detected in the LGE is due to Raldh3
expression, we found that loss of RA synthesis by Raldh3 resulted in
lack of RA activity in Raldh32/2 LGE explants but had no effect
on RA activity in meninges (Figure 1M–O). Using an Raldh22/2
mutant model we found that all RA activity detectable in wild-type
meninges at E14.5 was eliminated in Raldh22/2 meninges
(Figure 1G,J). Raldh22/2 cortical explants contained no RA
activity as observed in wild-type (Figure 1H,K), while RA activity
was still observed in Raldh22/2 LGE (Figure 1I,L). Together, the
above findings demonstrate that RA produced by Raldh3 in the
LGE can activate transcription in the basal ganglia, whereas RA
produced by Raldh2 in the meninges does not activate transcrip-
tion in the adjacent cortex.
Exposure of the reporter cells to a range of RA concentrations
between 1 nM and 1 mM provided a dose-response for RA
activity (Figure S1); a concentration of 1 nM was sufficient to
activate the reporter line as previously reported [26]. Thus, the
fact that RA activity was not detected in cortical explants from
E12.5 to E14.5 indicates that RA is present at very low levels in
the cortex. However, recent studies proposed a role for RA in
corticogenesis and additionally reported a value for the
concentration of RA in the mouse E14.5 cortex (0.28 mmole/
mg) [22], which is seven orders of magnitude higher than that
previously reported for mouse E13.5 forebrain (12 pmol/g) [27].
The former value (presented as mmole/mg rather than pmol/g) is
most likely in error as other studies reported RA concentrations
in adult mouse cortex as 16 pmol/g and adult striatum as
78 pmol/g [28], but this leaves in doubt how much RA was
actually detected in E14.5 cortex.
LGE-Derived Progenitors Maintain Their RA Activity In
Vitro
Our observation that RA activity during forebrain development
is due primarily to Raldh3 expression in the LGE prompted us to
investigate if neural precursors isolated from E14.5 LGE maintain
their Raldh3 expression and RA activity when expanded in vitro
under mitogen stimulation. Hence, we employed immunocyto-
chemistry with a Raldh3 antibody together with the tissue explant
RA bioassay using neurospheres generated from E14.5 LGE and
cortex of wild-type and Raldh32/2 embryos. RA activity and
Raldh3 immunostaining were detected in neurospheres derived
from wild-type E14.5 LGE (Figure 2C–D). In contrast, both
Raldh3 immunostaining and RA activity were eliminated in LGE-
derived neurospheres from Raldh32/2 embryos (Figure 2A–B).
Neither Raldh3 immunostaining nor RA activity were found in
neurospheres derived from the cortex of either wild-type or
Raldh32/2 embryos (Figure 2E–H). These results further confirm
that Raldh3 expression in the LGE is responsible for RA synthesis
and additionally showed that neurospheres expanded from LGE
cells maintain their RA activity.
GABAergic Differentiation of LGE-Derived Neurospheres
Depends on RA
We investigated whether RA has an effect on the differenti-
ation potential of regionally derived neurosphere cultures.
Neurospheres from LGE and cortex of E14.5 wild-type and
Author Summary
The vitamin A metabolite retinoic acid is an important
signaling molecule needed for development of the central
nervous system. Previous studies have shown a role for
retinoic acid in regulating genes involved in the genera-
tion of motor neurons both in the hindbrain and spinal
cord, but the role of retinoic acid in the forebrain has
remained elusive. Here, we investigated mice that lack the
ability to metabolize vitamin A into retinoic acid in the
forebrain. Although no defects were observed in the
generation of forebrain cortical neurons, we did observe a
serious deficiency in GABAergic neurons, which provide
inhibitory input to cortical neurons. Specifically, our results
reveal that retinoic acid is required for forebrain neurons
to activate an enzyme that converts glutamate to the
inhibitory neurotransmitter GABA. We also find that
retinoic acid treatment of human embryonic stem cells
could stimulate production of GABAergic neurons. Defi-
ciencies in GABAergic neurons have been associated with
several neurological disorders, including Huntington’s
disease, autism, schizophrenia, and epilepsy. Knowledge
of how GABAergic neurons are generated may aid efforts
to treat these diseases.
GABAergic Differentiation in the LGE Requires RA
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quently analyzed immunocytochemically with antibodies against
the pan-neuronal marker b-tubulin-III (Tuj1), the GABA-
synthesizing enzyme glutamic acid decarboxylase (Gad67), the
neural progenitor marker nestin, and the astrocytic marker glial
fibrillary acidic protein (GFAP). Many wild-type LGE neuro-
spheres untreated with RA were found to co-express Tuj1 and
Gad67, indicating they have differentiated and matured into a
GABAergic phenotype (44.3%613.0%), however very few Tuj1/
Gad67-positive cells were detected in differentiated cultures of
Raldh32/2 LGE neurospheres (13.2%64.1%) (Figure 3A–B,K).
Tuj1-expressing neurons that differentiated from cortical
Raldh32/2 neurospheres appeared to have a similar morphol-
ogy to those generated from cortical wild-type neurospheres, and
Gad67 was never detected (Figure 3C–D). Nestin-positive
progenitors and cells with an astrocytic morphology expressing
GFAP appeared similar in LGE and cortical differentiated
cultures derived from wild-type and Raldh32/2 neurospheres
(Figure 3E–H).
LGE neurospheres from both wild-type and Raldh32/2
embryos were differentiated in the presence of RA in order to
further test the effect of RA on GABAergic neuronal differentiation.
After 1 wk of differentiation in the presence of 100 nM RA, the
majority of the generated neurons in Raldh32/2 and wild-type
cultures were GABAergic, as observed by double staining for Tuj1
and Gad67 (Figure 3I–J). However, when cortical neurospheres
were differentiated in the presence of RA, Gad67 was never
detected in either wild-type or Raldh32/2 differentiating cultures
(Figure 3K–L). Quantification of GABAergic neuron differentiation
from wild-type and Raldh32/2 LGE neurospheres with or without
Figure 1. Endogenous RA activity in the developing forebrain. Tissues were cultured as explants on a monolayer of F9 RARE-lacZ RA-reporter
cells, then stained for b-galactosidase activity. (A–C) At E12.5, cortex and LGE were both negative, whereas eye was positive. (D–F) At E13.5, LGE and
eye explants induced RA activity in the reporter cells, but not cortex. (G–I) At E14.5, meninges and LGE induced RA activity while the reporter cells
surrounding E14.5 cortical explants remained negative. (J–L) For E14.5 Raldh22/2 (KO) tissues, meninges and cortex were negative, while LGE
explants remained positive. (M–O) For E14.5 Raldh32/2 (KO) tissues, meninges explants remained positive, while cortex and LGE were negative. For
each genotype and stage, tissues from at least three embryos were analyzed with similar results.
doi:10.1371/journal.pbio.1000609.g001
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in the presence of RA. The proportion of GABAergic cells derived
from Raldh32/2 LGE neurospheres increased significantly from
13.2%64.1% under control conditions to 83.37%611.75% when
the neurospheres had been differentiated in 100 nM RA
(Figure 3M). The proportion of GABAergic neurons in cultures of
wild-type LGE neurospheres increased from 44.3%613.0% under
control conditions to 76.45%611.75% after treatment with
100 nM RA (Figure 3M). Thus, E14.5 LGE derived cells from
Raldh32/2 embryoscanbe expanded asneurospheresandareable
to differentiate into neurons and glia, but they are unable to
differentiate into GABAergic neurons unless RA is added.
Figure 2. Raldh3 is responsible for RA activity in neurospheres derived from the LGE but cortex-derived neurospheres lack RA
activity. (A–D) Neurospheres generated from the LGE of E14.5 wild-type (WT) embryos exhibit Raldh3 immunoreactivity and they induce RA activity
when co-cultured with F9-RARE-lacZ RA-reporter cells (n=4); neurospheres derived from Raldh32/2 LGE always lacked both Raldh3 detection and
RA activity (n=4). (E–H) Neither Raldh3 nor RA activity were detected in cortex-derived neurospheres from either wild-type or Raldh32/2 (KO)
embryos (n=4).
doi:10.1371/journal.pbio.1000609.g002
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PLoS Biology | www.plosbiology.org 4 April 2011 | Volume 9 | Issue 4 | e1000609Figure 3. RA induces GABAergic differentiation in neurosphere-derived cells from the LGE. (A–B) Neurosphere-expanded wild-type (WT)
cells derived from the E14.5 LGE give rise to Gad67-positive and Tuj1-positive cells after 1 wk of differentiation; under the same conditions no Gad67-
positive cells were detected in differentiating cultures derived from Raldh32/2 (KO) LGEs. (C–D) Gad67 was not detected in differentiating cultures of
E14.5 neurospheres from either wild-type or Raldh32/2 cortex. (E–H) Cells derived from E14.5 Raldh32/2 LGE and cortex neurospheres both express
nestin and GFAP at indistinguishable levels from cells derived from wild-type neurospheres. (I–J) RA induces GABAergic differentiation of LGE-derived
neurospheres; addition of 100 nM RA for 1 wk in the differentiation medium of expanded LGE cells resulted in an increase of Gad67+/Tuj1+ neurons
in both wild-type and Raldh32/2 cultures. (K–L) Cortex-derived neurospheres treated with 100 nM RA exhibited no Gad67 detection. (M)
Quantification of the percentage of LGE neurosphere-derived Tuj1-positive neurons also positive for Gad67 showed that in differentiating medium
containing only fetal calf serum (FCS) with no added RA, the percentage of Gad67+/Tuj1+ cells derived from Raldh32/2 LGE neurospheres was
significantly lower than that of wild-type LGE neurospheres. Following addition of 100 nM RA to the differentiation medium for 1 wk, the majority of
Tuj1-positive neurons derived from both wild-type and Raldh32/2 LGE neurospheres were also Gad67-positive. The percentage was calculated by
dividing the immunopositive cell number with the total number of DAPI-stained nuclei. Values are listed as mean 6 SEM; * p,0.05; ** p,0.01;
*** p,0.001.
doi:10.1371/journal.pbio.1000609.g003
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GABAergic Differentiation in the LGE
The observation that RA generated by Raldh3 induces
GABAergic differentiation of neural precursors in vitro prompted
us to investigate if RA signaling is required for GABAergic
differentiation in the developing forebrain. We examined a panel
of markers for both neural progenitors and differentiated neurons
in forebrains from E14.5 wild-type and Raldh32/2 embryos.
Raldh3 protein was observed at high levels in the SVZ of the LGE;
Raldh3 was not detected in the Raldh32/2 forebrain (Figure 4A–
B). Nestin and RC2 immunoreactivity was not significantly
changed in Raldh32/2 versus wild-type basal ganglia at E14.5,
suggesting that generation of neural progenitors is not affected
when RA signaling is disrupted (Figure 4C–F). In order to
determine the proliferative capacity of these neural progenitors,
double immunohistochemistry was performed with the prolifera-
tion marker Ki67 and the radial glia/progenitor marker nestin
(Figure S2A–B). We observed no reduction in the number of LGE
proliferating progenitors in Raldh32/2 embryos compared to
control embryos, showing that both generation and proliferation of
neural progenitors is not affected when RA signaling is disrupted
(Figure S2C).
MAP2 immunostaining marking postmitotic neurons [29] was
unaffected in Raldh32/2 basal ganglia (Figure 4G–H). The
numbers of MAP2-expressing neurons were quantified in the
striatum, cortex, and septum from wild-type and Raldh32/2
Figure 4. Loss of RA signaling creates a defect in GABAergic differentiation in the LGE. Immunofluorescence was performed on E14.5
forebrain coronal sections of wild-type (WT) and Raldh32/2 (KO) embryos. (A–B) Raldh3 immunoreactivity in the subventricular zone of the LGE is
lost in the mutant. (C–H) Loss of Raldh3 does not affect detection of neural progenitor marker nestin, radial glial marker RC2, or neuronal marker
MAP2. (I–L) Detection of both GABA and Gad67 is greatly reduced in the LGE and septum of Raldh32/2 embryos. Similar results were observed for all
mutants analyzed (n=3). LGE, lateral ganglionic eminence; Spt, septum.
doi:10.1371/journal.pbio.1000609.g004
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these regions of the forebrain in Raldh32/2 embryos, confirming
that neurogenesis was not affected (Figure S2D).
A defect in GABAergic differentiation was observed when RA
signaling is lost in the basal ganglia. Gad67-positive cells are
normally present along the SVZ from the LGE to the septum
(Figure 4K), and the pattern of GABA immunoreactivity is
normally similar to Gad67 although GABA-positive cells extend
into the ventricular zone (Figure 4I); this is probably due to the fact
that while Gad67 immunoreactivity marks only cells with GABA
production (i.e. GABAergic cells), GABA immunoreactivity could
mark cells synthesizing GABA plus cells that uptake GABA
released by Gad67-positive cells. In Raldh32/2 embryos,
detection of both Gad67 and GABA was nearly eliminated in
the LGE and septum (Figure 4J,L). At E12.5, when Raldh3
expression in the LGE has just initiated, we observed that GABA
was detected in the MGE and LGE in a pattern that was not
significantly different between wild-type and Raldh32/2 fore-
brain; GABA detection in the LGE at E12.5 was at a lower level
than that seen at E14.5 (Figure S3A–B). As RA activity is not yet
detected in the LGE at E12.5 but is seen by E13.5 (Figure 1C,F),
these findings demonstrate that RA signaling initiating after E12.5
is required to stimulate the high level of GABAergic differentiation
normally observed in the LGE by E14.5.
The cellular source of RA in the LGE has previously been
associated with newly born neurons in the subventricular zone
expressing Raldh3 [24]. We analyzed Raldh3 immunoreactivity in
two distinct types of cells, radial glia and postmitotic neurons of the
LGE at E14.5. Double-labeling studies demonstrated that none of
the RC2-positive radial glia exhibit Raldh3 detection, although the
radial processes of these cells were observed next to Raldh3-
positive cells localized in the SVZ that did not possess radial
processes (Figure S4A–C). In contrast, most Raldh3-expressing
cells were also labeled with neuronal marker MAP2 (Figure S4D–
F). The above results provide further evidence that Raldh3-
expressing cells in the LGE are newly born neurons defining a
discrete region of the SVZ.
RA Is Required to Stimulate GABAergic Differentiation in
the Striatum
In E18.5 wild-type embryos, Raldh3 detection remains
strongest along the SVZ of the LGE (particularly high in the
dorsal LGE) with weaker detection further ventrally along the
septum; Raldh3 immunoreactivity was eliminated in Raldh32/2
forebrain (Figure 5A–B). As observed at E14.5, MAP2 immuno-
staining was unaffected in Raldh32/2 versus wild-type forebrain
at 18.5 (Figure 5G–H). At E18.5, GABAergic differentiation in the
striatum was nearly eliminated in Raldh32/2 forebrain as
monitored by Gad67 immunoreactivity (Figure 5C–D); GABA
detection was reduced in striatum but less so than Gad67 possibly
due to diffusion of GABA still generated ventral of the striatum
(Figure 5E–F). Thus, not all regions of the basal ganglia were
affected by the disruption of RA signaling, as both Gad67 and
GABA immunoreactivity appear relatively normal in the pallidum
and septum at E18.5 (Figure 5C–F).
The subcortical telencephalon is known to be the source of
GABAergic projection neurons that migrate radially from the
ventricular progenitor zone to reach their final destination. The
LGE gives rise to GABAergic striatal projection neurons [1,30–
35], while the MGE gives rise to GABAergic projection neurons of
the pallidum, septum, and nucleus basalis [1,30]. In order to
determine if differentiation of striatal projection neurons is affected
in E18.5 Raldh32/2 embryos, we examined Foxp1, a marker for
these neurons [36], and found that Raldh32/2 embryos display
normal Foxp1 immunoreactivity in the striatum (Figure 5I–J). This
observation supports our previous findings demonstrating that
Raldh3 is not required to generate DARPP32-positive neurons,
another marker of striatal medium-sized spiny projection neurons
[20]. Instead, our findings demonstrate that RA is required for
striatal projection neurons to acquire a GABAergic fate.
Our results indicate that RA is required to stimulate GABA
synthesis in LGE-derived progenitors. To characterize other
aspects of the GABAergic phenotype in Raldh32/2 mutants, we
analyzed expression of the vesicular GABA transporter (VGAT,
Viaat), a transporter that mediates accumulation of GABA into the
synaptic vesicles before exocytotic release to the synaptic cleft [37].
Expression of VGAT appeared normal in Raldh32/2 forebrain
(Figure S5A–B), indicating that RA is not required for this aspect
of GABAergic differentiation.
Next, we wanted to investigate whether disruption of RA
signaling could induce defects in the specification of other
neuronal populations. Previous studies have shown that loss of
Raldh3 or RARb in the striatum results in down-regulation of
dopamine receptor D2 in the nucleus accumbens [20,21].
However, in Raldh32/2 forebrain no difference was found in
the expression of tyrosine hydroxylase (TH), a marker of
dopaminergic neurons (Figure S5C–D). Also, we observed no
difference in vesicular glutamate transporter (VGLUT), a marker
of glutamatergic neurons (Figure S5E–F).
In addition to neuronal markers, we examined whether loss of
RA affects glia. We showed above that radial glia differentiation is
not affected by loss of Raldh3 (Figure 4E–F). We also analyzed
astrocyte differentiation by analyzing expression of the astrocytic
marker GFAP. We did not detect any difference in GFAP
immunoreactivity in E18.5 Raldh32/2 forebrain compared to
wild-type controls (Figure 5K–L). Our findings thus suggest that
RA is not required for gliogenesis or generation of radial
projection neurons.
Taken together, our observations at E12.5–E18.5 demonstrate
that RA is required to stimulate a high level of GABAergic
differentiation first in the LGE and then later in the striatum but
that a Raldh3-independent mechanism for GABAergic differen-
tiation occurs in the MGE/pallidum and septum.
RA Is Required for Differentiation of LGE-Derived
GABAergic Interneurons Migrating to the Cortex and
Olfactory Bulb
In addition to GABAergic projection neurons, progenitor cells
in the LGE produce GABAergic interneurons that migrate
tangentially mostly within the cortical intermediate zone, whereas
GABAergic interneurons migrating from the MGE disperse into
the cortical plate [5,38–40]. Also, cells derived from the dorsal
SVZ of the LGE generate many olfactory bulb interneurons via a
rostral migratory pathway [40–42]. At E18.5, Gad67 immunore-
activity normally extends from the striatum into the intermediate
zone of the cortex marking a population of LGE-derived
interneurons, but this zone of Gad67 detection was markedly
reduced in Raldh32/2 cortex (Figure 5C–D). Dlx2 is an early
marker of GABAergic progenitors in the basal ganglia that is
required for GABAergic interneuron migration to the cortex [14].
Dlx2 immunoreactivity was not changed in Raldh32/2 forebrain
from E12.5–E18.5, demonstrating that interneurons are generated
in the basal ganglia and migrate to the cortex in the absence of RA
signaling (Figure S3C–H). Additionally, detection of Gad67 in the
Raldh32/2 olfactory bulb was also clearly reduced compared to
wild-type (Figure 5M–N). Apart from the dorsal LGE, recent
studies have shown that additional telencephalic areas may also
contribute to olfactory bulb interneurons [43–45], which may
GABAergic Differentiation in the LGE Requires RA
PLoS Biology | www.plosbiology.org 7 April 2011 | Volume 9 | Issue 4 | e1000609Figure 5. RA is required for GABAergic differentiation of striatal projection neurons and interneurons migrating to the cortex and
olfactory bulb. Immunofluorescence was performed on E18.5 forebrain coronal sections of wild-type (WT) and Raldh32/2 (KO) embryos. (A–B)
Raldh3 immunoreactivity in the subventricular zone of the LGE and septum is lost in the mutant. (C–F) In Raldh32/2 embryos, detection of both
Gad67 and GABA is greatly reduced in the LGE, striatum, and cortex (note arrows for Gad67); septum is unaffected. (G–L) Loss of Raldh3 does not
affect detection of neuronal marker MAP2, striatal projection marker Foxp1, or astrocytic marker GFAP. (M–N) Raldh32/2 embryos exhibit a
reduction of Gad67-positive neurons migrating from the LGE to the olfactory bulb when compared to wild-type. All mutants analyzed generated
similar results (n=3). iz, intermediate zone; LGE, lateral ganglionic eminence; OB, olfactory bulb; P, pallidum; Spt, septum.
doi:10.1371/journal.pbio.1000609.g005
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tivity in the Raldh32/2 olfactory bulb. The above findings
provide evidence that RA synthesis controlled by Raldh3 is
required for GABAergic differentiation of interneurons that
originate from progenitors in the LGE then migrate tangentially
to the cortex and olfactory bulb.
RA Stimulates GABAergic Differentiation of Human
Embryonic Stem Cells
We investigated whether our findings may be useful to generate
GABAergic neurons from human embryonic stem (ES) cells for
potential cell replacement therapies. Following RA treatment of
embryoid bodies and propagation of neural rosettes, cultures were
processed immunocytochemically with antibodies against Pax6 (a
marker for neural progenitors), Doublecortin (DCX; a marker
for immature migrating neurons), the pan-neuronal marker Tuj1,
plus GABA and Gad67. With no RA added in the differentiation
medium a large proportion of the cells were Pax6-positive
(79.9%65.01%), indicating they were neural progenitors
(Figure 6J,M), and many cells exhibiting neuronal processes were
Tuj1-positive (32.8%610.3%) and colocalized with DCX
(31.3%68.6%), suggesting they were immature neurons
(Figure 6G,M). However, very few Gad67 (2.7%60.6%) positive
cells were detected in cultures with no RA added, suggesting that
GABAergic differentiation is not favored under these conditions
(Figure 6A,D). Treatment of embryoid bodies with 1 mMR A
resultedinasignificantincreaseinboththenumberofTuji1/DCX+
neurons that were forming extensive neuronal networks and
GABAergic neurons detected with Gad67 (16.2%62.1%)
(Figure 6B,E,M). Moreover, the proportion of Pax6-positive cells
was reduced to almost half with 1 mM RA (49.9%611.6%),
suggesting that more progenitor cells had differentiated to immature
migrating neurons co-expressing Tuj1 and DCX (Figure 6H,K,M).
Addition of 10 mM RA further increased the percentage of
GABAergic neurons positive for Gad67 (41.9%610.7%)
(Figure 6C,F,M) and further decreased the number of Pax6-positive
progenitors (17.9%64.9%) (Figure 6L,M). Under these differenti-
ation conditions, RA was able to drive GABAergic differentiation in
almost half of the cells generated (Figure 6M), suggesting that RA
treatment is quite useful for induction of GABAergic differentiation
in vitro.
To gain further insight on the subtype identity of the RA-
induced GABAergic neurons generated in our cultures, we
examined expression of region-specific transcription factors
previously associated with the specification of both GABAergic
interneurons and projection neurons. Many Tuj1-positive cells
were also immunopositive for Dlx2, which is expressed in
GABAergic precursors in the basal ganglia of the telencephalon,
differentiating into both interneurons and striatal projection
neurons (Figure S6A). However, no Tuj1-positive cells were found
to be positive for Foxp1, a striatal projection neuron marker
(Figure S6B). Lim1/2 is a LIM homeodomain protein marking
interneurons of the diencephalon and spinal cord [17,46–48].
Many GABA-positive neurons also expressed Lim1/2, suggesting
they acquire a GABAergic interneuron phenotype (Figure S6C).
Islet1 (Isl1), another LIM homeodomain protein, is expressed in
the ventral forebrain where it marks telencephalic GABAergic
projection neurons; Isl1 also marks diencephalic interneurons
when co-expressed with Lim1/2 and GABA [46,48]. No cells in
our culture co-expressed GABA and Isl1, further suggesting that
GABA-positive neurons in our cultures do not acquire striatal
projection neuron or diencephalic interneuron identities (Figure
S6D). We found that 43.7%611.94% of GABA-positive cells
expressed Lim1/2 and 37.5%611.5% expressed Dlx2 (Figure
Figure 6. RA induces GABAergic differentiation of human
embryonic stem cells. Embryoid bodies derived from H9 human
embryonic stem cells were treated for 3 d with vehicle, 1 mM RA, or
10 mM RA; then neural rosettes differentiating from these cultures were
analyzed immunocytochemically 18 d after RA treatment ended. (A–F)
RA treatment increased the number of neurons positive for Gad67 and
GABA. (G–I) Tuj1 and DCX double-staining shows that RA treatment
increases the number of Tuj1-positive neurons, and essentially all are
also positive for DCX, which marks migrating neurons. (J–L) RA
treatment decreased the number of neurons positive for the neural
progenitor marker Pax6. (M) Quantitative analysis of various cell types in
differentiating cultures showed that 1 mMR Ao r1 0mM RA significantly
induced the GABAergic neuron phenotype (Gad67-positive) with a
concomitant decrease of Pax6-expressing neural progenitors. Percent-
ages were calculated by dividing the immunopositive cell number with
the total number of DAPI-stained nuclei. Data are presented as mean 6
SEM; * p,0.01 and ** p,0.001 (untreated versus treated).
doi:10.1371/journal.pbio.1000609.g006
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differentiation protocol induces a heterogeneous population of
GABA-positive interneurons acquiring either telencephalic or
spinal cord identities, but that it does not favor generation of
GABA-positive striatal projection neurons.
RA Is Not Required for Radial Expansion of the Embryonic
Cortex
Previous studies using an Rdh10 ethylnitrosourea (ENU) mutant,
which reduces retinaldehyde needed for Raldh2 to catalyze RA
synthesis in the meninges, suggested that this source of RA is
required for radial expansion of the cortex; a reduction in radial
expansion of the cortical postmitotic neuronal layer was proposed
to result in a concomitant lateral increase in the proliferative
progenitor population in the ventricular zone [22]. Raldh22/2
embryos, which completely lack meninges RA activity
(Figure 1G,J), present an excellent model to examine whether
RA is required for corticogenesis since Raldh2 catalyzes the final
step of RA synthesis in the meninges. At E14.5, the head region of
Raldh22/2 embryos appeared to have developed relatively
normally while they invariably displayed stunted forelimbs
(Figure 7A–B), which we have previously shown is due to a lack
of RA synthesis by Raldh2 in trunk mesoderm [49,50]. Thus,
Raldh22/2 mutants do not exhibit massive head deformities like
those reported for Rdh10 mutants [51]. We analyzed expression of
Tuj1 and the proliferative marker Ki67 in coronal brain sections
of both wild-type and Raldh22/2 embryos at E14.5. The medial-
lateral length of the ventricular zone in the dorsal forebrain of the
Raldh22/2 mutant appeared similar to that of the wild-type
embryo (Figure 7C–D). Moreover, double immunostaining for
Tuj1 and Ki67 revealed no changes in radial expansion of the
postmitotic Tuj1-expressing cortical layer nor the Ki67 prolifer-
ative zone in the Raldh22/2 cortex when compared to wild-type
(Figure 7E–J). Examination of MAP2, another marker for
postmitotic neurons, also demonstrated no difference in medial-
lateral length for the mutant dorsal ventricular zone (Figure S7A–
B) and no difference in radial width for the mutant cortex (Figure
S7C–D). Finally, examination of RC2, a marker of radial glia
whose somata reside in the ventricular zone of the cortex and
whose radial processes span the entire distance to the pial surface,
showed no difference between the Raldh22/2 and wild-type
cortex (Figure S7E–F). The fact that Raldh22/2 embryos retain a
normal ratio of cortical progenitors to postmitotic neurons with no
apparent morphological defects, in conjunction with a complete
lack of RA activity in mutant meninges and cortical explants,
suggests that RA is not required for embryonic corticogenesis. The
contradiction between our results with Raldh22/2 embryos and
the results of others with Rdh10 mutants [22] may be explained by
the observation that Rdh10 mutants, unlike Raldh22/2 embryos,
exhibit severe craniofacial defects that distort the cranium and
forebrain possibly resulting in a thinner cortex [51].
Expression of Retinoic Acid Receptors in the Developing
Forebrain
Previous studies have shown that RARa and RARb are
expressed during mouse forebrain development, whereas RARc is
undetectable [52,53]; RARa was reported to be widespread in the
embryonic forebrain, while RARb was detected primarily in the
striatum and is induced by RA. We examined expression of RARa
and RARb in E18.5 wild-type forebrains by in situ hybridization.
RARa mRNA was widespread in the E18.5 forebrain including
both the striatum and cortex, but expression was low or
undetectable in the ventricular zone (Figure S8A). RARb mRNA
wasdetected inthe striatumbutnotinthecortexorventricularzone
(Figure S8B). Taken together with our observation that the LGE/
striatum is a major localized site of RA synthesis during forebrain
development due to Raldh3 expression, overlapping expression of
both RARa and RARb in the striatum further suggests that this is a
major site of local RA-mediated induction and signaling.
Discussion
In this study we demonstrate a novel requirement of RA
generated by Raldh3 for GABAergic differentiation in the basal
ganglia. In contrast, RA activity is not detected in the cortex at any
stages examined despite detection of RA activity in the adjacent
meninges, which requires Raldh2. Even if the cortex does receive a
small amount of RA from the meninges that we cannot detect, our
findings with Raldh22/2 embryos lacking RA activity in the
meninges demonstrate that this source of RA is unnecessary for
cortical expansion as suggested by a recent study [22]. Thus,
unlike the cortex, the LGE represents an unambiguous site of RA
action during forebrain development, and loss of RA in the LGE
results in a loss of GABAergic differentiation.
Our studies revealed that at E12.5, when Raldh3 expression is
barely detectable in the LGE and RA activity is not yet detected,
Raldh32/2 embryos maintain expression of the regulatory gene
Dlx2 and early aspects of GABAergic differentiation in the
progenitor domains of the basal ganglia. However, by E14.5,
when Raldh3 expression has intensified in the LGE and RA activity
is easily detectable, RA generated by Raldh3 is required to
stimulate GABAergic differentiation in the LGE by inducing
Gad67 needed for GABA synthesis. At E18.5, Raldh3 is required
to maintain GABAergic differentiation in the LGE, whereas a
Raldh3-independent mechanism controls GABA synthesis in the
MGE and septum. This observation suggests that the LGE is the
main site of RA action along the SVZ. We observed that Raldh3
expression in newly generated neurons at the border of the
proliferative and postmitotic zones in the LGE coincides with a
region that generates both GABAergic striatal projection neurons
and GABAergic interneurons [5,31–34,40]. Our studies in
Raldh32/2 embryos revealed that RA signaling stimulates a
GABAergic phenotype in LGE-derived interneurons migrating to
the olfactory bulb and cortex and that RA is required for Foxp1-
positive striatal projection neurons to further differentiate to a
GABAergic fate. As Dlx2 and VGAT were still expressed normally
in the absence of RA, the role of RA in GABAergic differentiation
may be limited to stimulation of Gad67 activity in the LGE to
promote GABA synthesis.
As the appearance of GABAergic interneurons in the olfactory
bulb and cortex is reduced rather than eliminated, our findings
suggest that interneurons can still migrate to these locations in the
absence of RA but that less interneurons have matured to a
GABAergic phenotype. Other studies have shown that Gsx2 (Gsh2),
a homeobox gene specifying ventral character in the forebrain, is
required for Raldh3 expression in the LGE [54] and that Gsx2 is
required for specification of GABAergic interneurons that migrate
from the LGE to the olfactory bulb [13]. In addition,
differentiation of DARPP-32 striatal projection neurons is greatly
reduced in Gsx2 null embryos but not in conditional Gsx2 mutants
when Gsx2 is progressively inactivated from E10.5–E18.5 [13] and
also not in Raldh32/2 mutants [20]. Thus, early expression of
Gsx2 is required for correct DARPP-32 striatal projection neuron
development, a time when there is no Raldh3 expression in the
forebrain. Taking into consideration the above, one can conclude
that RA signaling exerts a specific role in specifying the
GABAergic phenotype both for production of GABAergic
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neurons to a GABAergic fate. Examination of the Gad67 promoter
proximal region revealed no evidence of a canonical RA response
element (unpublished data), suggesting that Gad67 may be an
indirect target or may be controlled post-transcriptionally by RA
signaling in the basal ganglia during GABAergic differentiation. As
it is clear that RARa and RARb are both expressed in the basal
ganglia, null mutants or antagonists for these RA receptors may be
useful to further examine the mechanism through which RA
functions during stimulation of GABAergic differentiation. Fur-
ther, as we show that endogenous RA signaling is preserved in
primary LGE neurosphere cultures and is required to generate
GABAergic neurons in vitro, such cells may prove useful in
studying the mechanism of RA action during GABAergic
differentiation.
A previous study suggested that Foxc1 mutants fail to form a
complete forebrain meninges and exhibit increased lateral
expansion of the cortical ventricular zone and reduced neuro-
genic radial expansion due to the loss of RA produced by Rdh10
and Raldh2 in the meninges [22]. The major conclusions of that
study were drawn by comparison of the cortical phenotype of the
Foxc1 mutants with that of an Rdh10 ENU mutant [22,55].
However, our studies on Raldh22/2 embryos lacking RA activity
in the meninges demonstrate that RA is not required for radial
expansion of the embryonic cortex. Additionally, RA receptors
were not detected in the ventricular zone of the developing
cortex, where RA was proposed to be required to induce
neurogenic division of cortical progenitors. Together, these
findings suggest that the dorsal forebrain phenotype in Foxc1
mutants is RA-independent. The Rdh10 ENU mutant employed
for those forebrain studies [22] exhibits a very similar phenotype
to another published Rdh10 ENU mutant, which has severe
neural crest-derived craniofacial defects that are responsible for
distortion of the cranium as well as forebrain [51]. Thus, reduced
radial expansion of the cortex and increased lateral expansion of
the ventricular progenitor zone reported for Rdh10 mutants [22]
may not be due to a specific effect of RA on corticogenesis but
rather a defect in cranial neural crest migration and differenti-
ation that leads to the altered cortical morphology. Indeed, Rdh10
mutants lack all RA activity in the head during the time when
cranial neural crest is migrating due to loss of all retinaldehyde
synthesis [51], whereas Raldh22/2 embryos still retain most
cranial RA synthesis during this time due to expression of Raldh1
and Raldh3 in ocular and olfactory tissues [56]. Thus, head
development in Raldh22/2 embryos is not grossly altered,
allowing us to conclude that a lack of cranial RA activity
specifically in the meninges does not lead to a defect in radial
expansion of the cortex. Furthermore, Raldh2 is not expressed in
the dorsal meninges until E12.5 [22] or E13.5 [25], while the
lengthening of the dorsal forebrain in Foxc1 mutants is already
evident at E12.5 [22]. Based on the above, it seems unlikely that
RA produced and secreted in the dorsal meninges could be the
neurogenic factor inducing the switch from symmetric to
asymmetric division in the ventricular zone to affect embryonic
cortical expansion. Alternatively, RA generated in the meninges
by Rdh10 and Raldh2 might have another function. RA could
diffuse in the opposite direction and control development of the
skull, which is populated by cranial neural crest cells. Interest-
ingly, a recent study showed that ablation of all three RA
receptors (RAR alpha, beta, and gamma) in cranial neural crest
cells results in agenesis or malformations of most of the
craniofacial skeletal elements including the frontal and parietal
Figure 7. Cortical expansion appears normal in embryos lacking RA synthesis in meninges. (A–B) Raldh22/2 embryos at E14.5 exhibit
relatively normal craniofacial development while they display stunted forelimbs (f). (C–D) Tuj1 labeling of postmitotic neuronal layer in E14.5 wild-
type (WT) and Raldh22/2 (KO) forebrains. Arrows (same length) demonstrate that Raldh22/2 mutant does not exhibit a change in medial-lateral
width of the dorsal ventricular zone (vz; labeled with DAPI) compared to wild-type. (E–J) Double-labeling of E14.5 forebrains with Tuj1 (green) and
Ki67 (red; proliferative progenitor layer). Arrows (same length) demonstrate that the Raldh22/2 forebrain exhibits no change in radial expansion of
the cortex (cx) or ventricular zone (vz) compared to wild-type. Similar results were observed for all mutants analyzed (n=3).
doi:10.1371/journal.pbio.1000609.g007
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Additionally, Foxc1 hypomorphic mutants also exhibit malforma-
tion of the frontal bone [58], providing further evidence that RA
generated in the meninges downstream of Foxc1 may function in
cranial neural crest differentiation.
RA treatment is known to facilitate terminal differentiation of
neural progenitors derived from ES cells [48,59–63]. Here we
demonstrated that exposure of human ES-derived embryoid
bodies to high concentrations of RA promotes differentiation of
neuronal precursors to a high percentage of immature GABAer-
gic neurons. Interestingly, although a low endogenous concen-
tration of RA is sufficient to stimulate GABAergic differentiation
of cells in the LGE at E14.5, a high concentration of RA is
needed for GABAergic differentiation in embryoid bodies
derived from ES cells. This may be due to the much more
primitive nature of cells in an embryoid body (similar to cells in
an early gastrula) compared to neuroepithelial cells of the late
embryonic forebrain. As RA binds directly to DNA-bound
nuclear receptors that interact with co-repressors and co-
activators, we suggest that high concentrations of RA may exert
tremendous epigenetic effects on embryoid body cells, driving
them to both a neuronal and GABAergic fate. In addition, our
RA treatment protocol generated GABAergic neurons exhibiting
expression of interneuron transcription factors of either anterior
(forebrain) or posterior (spinal cord) identity, but not striatal
projection neuron identity. A previous study proposed that
mouse ES cells differentiating in medium without RA acquired a
GABAergic identity of ventral forebrain co-expressing Gad67
and Isl1 (most likely striatal projection neurons), while exposure
to RA resulted in acquisition of a spinal cord interneuron
identity [48]; those studies differed from ours in that RA
treatment occurred at a later window during embryoid body
formation and a lower concentration of RA was used. Thus,
differences in the effects of RA on GABAergic interneuron
identity in various culture systems may be dependent upon the
timing and concentration of RA used.
Production of the inhibitory neurotransmitter GABA in the
central nervous system depends on local neurons, and disturbed
GABAergic neuron function has been associated with numerous
neurological disorders including Huntington’s disease, autism,
schizophrenia, bipolar depression, and epilepsy [9–12]. GABAer-
gic interneurons are a particularly attractive cell population for
cell-based therapies of these disorders due to their ability to
migrate, differentiate, and function following transplantation [64–
66]. GABAergic interneuron precursors derived from mouse ES
cells were shown to migrate, survive for several months, and
exhibit neurochemical and electrophysiological characteristics of
mature interneurons when transplanted into postnatal cortex [67].
Additionally, transplantation of GABAergic interneuron precur-
sors reduced the number of seizures in epileptic mice [68]. Thus,
generation of GABAergic interneurons from RA-treated human
ES cells as we report here coupled with isolation of cells with
forebrain character may provide useful candidate cells in cell




Raldh32/2 embryos exhibiting postnatal lethality just after
birth were previously described [20]. Raldh22/2 embryos
exhibiting midgestation lethality have been described previously
[69]. To prevent Raldh22/2 early lethality, the maternal diet was
supplemented for a short time with a very low dose of RA as
described previously [50]. Briefly, 0.1 mg of all-trans-RA (Sigma
Chemical Co.) was added per gram of standard mouse chow and
provided fresh to pregnant females at E6.75–E8.75. At E9.25 mice
were returned to standard chow until embryos were collected at
E14.5; Raldh22/2 mutants obtained with this method invariably
exhibit stunted forelimbs and interdigital defects, demonstrating a
loss of RA function in regions where Raldh2 is responsible for RA
synthesis [50]. Dietary supplementation with this dose of RA is
indeed low as HPLC measurements have shown that it provides
less RA to embryos than Raldh2 normally generates [70].
Administered RA is cleared within 12–24 h after treatment ends
[69], thus allowing one to examine embryos at E10.5–E14.5 that
now lack RA activity normally generated by Raldh2. Embryos
were genotyped by PCR analysis of yolk sac DNA and were staged
by designating noon on the day of the vaginal plug as E0.5. All
mouse studies conformed to the regulatory standards adopted by
the Animal Research Committee at the Sanford-Burnham
Medical Research Institute.
Neurosphere Preparation and Differentiation
Lateral ganglionic eminence (LGE) and cortex were dissected
from E14.5 wild-type and Raldh32/2 mutant embryos and
incubated in DMEM containing 0.1% trypsin and 0.05% DNase
for 15 min at 37uC followed by mechanical dissociation. The cells
were spun down and resuspended at a concentration of 100,000
cells/ml in basic medium DMEM-F12 supplemented with B27,
10 ng/ml basic fibroblast growth (bFGF) factor, and 20 ng/ml
epidermal growth factor (EGF). No apparent differences in growth
rate or appearance were observed for wild-type compared to
Raldh32/2 neurosphere cultures. Neurospheres were differenti-
ated by culturing on plates pre-coated with poly-L-ornithine. EGF
and bFGF were removed from the expansion medium and 1%
serum was added (differentiation medium). The spheres were
maintained under differentiation conditions for 7 d in the presence
or absence of 100 nM RA before fixation.
Explant Culture and RA Bioassay
Tissue explants or neurospheres from wild-type and mutant
embryos were cultured overnight on Sil-15 F9-RARE-lacZ RA
reporter cells followed by detection of b-galactosidase activity as
previously described [26].
Immunohistochemistry and In Situ Hybridization
E12.5–E14.5 heads and E18.5 brains were fixed overnight at
4uC in 4% paraformaldehyde and paraffin sections (7 mm) were
processed immunohistochemically as described [71]. The primary
antibodies included rabbit anti-Raldh3 1:50 [72], mouse anti-
nestin 1:100 (Millipore), mouse anti-RC2 1:100 (Developmental
Studies Hybridoma Bank at University of Iowa; DSHB), mouse
anti-MAP2 1:200 (Sigma; M4403), rabbit anti-GABA 1:500
(Millipore), mouse anti-Gad67 1:50 (Millipore; MAB5406), rabbit
anti-GFAP 1:1000 (Dako), rabbit anti-Foxp1 1:100 (Abcam),
rabbit anti-Ki67 1:200 (Abcam), rabbit anti-Dlx2 1:100 (Abcam),
mouse anti-VGAT 1:200 (Synaptic Systems), rabbit anti-VGLUT
(Synaptic Systems), and mouse anti-TH (Sigma). In situ hybrid-
ization of E18.5 brain sections was performed as described [73]
using RARa and RARb riboprobes.
Human Embryonic Stem Cell Culture and Differentiation
Human ES cells (line H9) were cultured and passaged weekly on
a feeder of irradiated embryonic mouse fibroblasts as described
previously [74]. The protocol for RA-induced GABAergic
differentiation was based on previous methods [75]. Briefly,
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growth medium in non-adherent plates for 3 d, followed by RA
treatment for 3 d (RAd3). RA was removed and the RAd3 EBs
were plated on culture dishes pre-coated with poly-L-ornithine
and fibronectin and cultured for an addition 4 d (RAd7) in serum-
free neuronal induction medium, comprised of neurobasal
medium supplemented with B27, bFGF, and EGF. At RAd7
neuroepithelial rosettes were isolated mechanically from the
differentiation cultures with a 2 ml serological pipette. After
isolation, rosettes were replated in the same neuronal induction
medium for an additional 14 d (RAd21) before fixation.
Immunocytochemistry
Immunocytochemistry on neurospheres and ES cells was
carried out as described [75]. Primary antibodies used included
rabbit anti-GABA 1:1,000 (Millipore), mouse anti-Gad67 1:200
(Millipore; MAB5406), rabbit anti-GFAP 1:1,000 (Dako), mouse
anti-Tuj1 1:1,000 (Covance), and guinea pig anti-DCX 1:500
(Millipore), rabbit anti-Dlx2 1:200 (Abcam, AB18188), rabbit anti-
Foxp1 1:100 (Abcam), mouse anti-Islet-1 1:100 (40.2D6) (DSHB),
and mouse anti-Lim1/2(4F2) 1:200 (DSHB).
Quantitation of Immunoreactivity
Immunopositive cells and total DAPI-stained nuclei were
counted to calculate the percentage of immunopositive cells. Five
randomly picked areas from three independent experiments were
counted for each marker. Data were presented as mean 6 SEM;
for pair-wise analysis of treatment conditions and/or genotypes, an
ANOVA test was used.
Supporting Information
Figure S1 Dose response of F9 RARE-lacZ RA-reporter cell line
to RA. (A–E) Cells were cultured in 24-well plates and treated for
18–20 h in serum-free medium with different concentrations of
RA ranging from 1 nM to 1000 nM as indicated. Cells were then
fixed and assayed for b-galactosidase activity.
Found at: doi:10.1371/journal.pbio.1000609.s001 (1.96 MB TIF)
Figure S2 Comparison of radial glia proliferation and neuro-
genesis in absence of RA. (A–B). Double-labeled immunofluores-
cence was performed on E14.5 forebrain coronal sections of wild-
type (WT) and Raldh32/2 (R3KO) embryos for radial glia
marker nestin and proliferation marker Ki67. (C) Quantification of
the ratio of double positive cells in the proliferative zones of the
LGE showed that the majority of radial glia are proliferating and
demonstrated that Raldh32/2 embryos exhibit no defect in radial
glia proliferation. (D) Quantification of the number of MAP2-
expressing neurons in an equal area of striatum, cortex, and
septum from both wild-type and Raldh32/2 embryos demon-
strates that neurogenesis occurs normally in the mutant forebrains.
The percentage was calculated by dividing the total number of
DAPI-stained nuclei by the MAP2 immunopositive cell number.
Values are listed as mean 6 SEM.
Found at: doi:10.1371/journal.pbio.1000609.s002 (8.88 MB TIF)
Figure S3 Dlx2 and GABA immunoreactivity in embryonic
forebrain. (A–B) At E12.5, GABA is expressed in the mantle
zones of the MGE and LGE and shows no change in expression
in Raldh32/2 (R3KO) embryos compared to wild-type (WT).
(C–D) At E12.5, Dlx2-expressing cells extend throughout the
proliferative zones of both the MGE and LGE (with weaker
streams of cells emanating into the cortex) and no change is
observed in Raldh32/2 embryos. (E–F) At E14.5, Raldh32/2
embryos continue to exhibit no difference in Dlx2 expression,
which has now further expanded. (G–H) At E18.5, the
distribution of Dlx2-expressing cells in the cortex appears normal
in Raldh32/2 embryos compared to wild-type. cp, cortical plate;
iz, intermediate zone; LGE, lateral ganglionic eminence; m,
marginal layer; MGE, medial ganglionic eminence; svz, subven-
tricular zone.
Found at: doi:10.1371/journal.pbio.1000609.s003 (4.94 MB TIF)
Figure S4 Raldh3-positive cells identified as MAP2-positive
neurons in the SVZ. Double-labeled immunofluorescence was
performed on wild-type E14.5 forebrain coronal sections at the
same rostrocaudal plane as those presented in Figure 4. (A–C)
Raldh3 does not colocalize with the radial glia cell marker RC2.
(D–F) The majority of Raldh3-positive cells colocalize with the
neuronal cell marker MAP2. SVZ, subventricular zone; VZ,
ventricular zone.
Found at: doi:10.1371/journal.pbio.1000609.s004 (4.38 MB TIF)
Figure S5 RA signaling is not required for expression of the
vesicular GABA transporter or for differentiation of dopaminergic
and glutamatergic neurons in the forebrain. Immunofluorescence
was performed on E18.5 forebrain coronal sections of wild-type
(WT) and Raldh32/2 (KO) embryos. (A–B) Expression of the
vesicular GABA transporter (vGAT) is not reduced in mutant
forebrain. (C–D) Mutant embryos exhibit normal expression of
tyrosine hydroxylase (TH), a marker of dopaminergic neurons,
and of vesicular glutamate transporter (VGLUT), a marker of
glutamatergic neurons (E–F).
Found at: doi:10.1371/journal.pbio.1000609.s005 (8.94 MB TIF)
Figure S6 Phenotypic analysis of RA-induced GABAergic
neurons derived from human embryonic stem cells. (A–B) In
RA-treated cultures, Tuj1-positive neuron populations were
immunolabeled with Dlx2, the ventral forebrain marker of
GABAergic precursors, whereas no neurons were co-labeled with
Foxp1, a marker of GABAergic striatal projection neurons. (C–D)
GABA-positive cells were positive for spinal cord interneuron
marker Lim1/2, but not for Islet1, a marker of both striatal
projection neurons and interneurons of the diencephalon. (E)
Quantification of GABA-positive cells that also express either
Lim1/2 or Dlx2; as both anti-GABA and anti-Dlx2 were derived
in the same species, we employed deconvolution microscopy to
distinguish between the nuclear localization of Dlx2 and
cytoplasmic localization of GABA; 43.7611.9 of GABA-positive
cells co-labeled with Lim1/2, and 37.5611.5 were co-labeled with
Dlx2.
Found at: doi:10.1371/journal.pbio.1000609.s006 (4.82 MB TIF)
Figure S7 Loss of RA synthesis in the meninges does not affect
radial expansion of the cortex. (A–B) MAP2 labeling of post-
mitotic neuronal layer. Arrows (same length) demonstrate that
Raldh22/2 mutant does not exhibit a change in medial-lateral
width of the dorsal ventricular zone (vz). (C–D) MAP2 labeling
shows that Raldh22/2 mutant has normal radial expansion of
cortex (cx). (E–F) RC2 (radial glia) labeling; mutant has normal
radial expansion of dorsal cortex.
Found at: doi:10.1371/journal.pbio.1000609.s007 (2.87 MB TIF)
Figure S8 Expression pattern of RARa and RARb in
embryonic forebrain. Representative coronal sections are illustrat-
ed for each gene examined by in situ hybridization in wild-type
embryos at E18.5. (A) RARa is expressed both in the developing
striatum and cortex. (B) RARb transcripts were highly expressed
striatum but not the cortex. Neither gene was expressed in the
ventricular zone. Cx, cortex; vz, ventricular zone.
Found at: doi:10.1371/journal.pbio.1000609.s008 (3.42 MB TIF)
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